FDA signs off on Lilly’s new antibody drug, bebtelovimab, which is effective against the omicron variant kdunleavy Fri, 02/11/2022 – 17:32 More: FDA signs off on Lilly's new antibody drug, bebtelovimab, which is effective against the omicron variant Source: fierce
read morePfizer’s and Lilly’s JAK inhibitor safety concerns prompt Europe to scrutinize drug class kdunleavy Fri, 02/11/2022 – 15:33 More: Pfizer's and Lilly's JAK inhibitor safety concerns prompt Europe to scrutinize drug class Source: fierce
read morePfizer stalls COVID-19 vaccine app as it awaits data on third dose in young kids fkansteiner Fri, 02/11/2022 – 14:41 More: Pfizer stalls COVID-19 vaccine app as it awaits data on third dose in young kids Source: fierce
read moreFDA sets an example through Eli Lilly, Innovent’s PD-1, rocking the boat for future contenders: analyst aliu Fri, 02/11/2022 – 11:28 More: FDA sets an example through Eli Lilly, Innovent’s PD-1, rocking the boat for future contenders: analyst Source: fierce
read moreIpsen telegraphs $400M deal for consumer healthcare split fkansteiner Fri, 02/11/2022 – 09:18 More: Ipsen telegraphs 0M deal for consumer healthcare split Source: fierce
read moreLilly back in COVID-19 antibody game with $720 million deal with U.S. for omicron-busting hopeful kdunleavy Fri, 02/11/2022 – 09:17 More: Lilly back in COVID-19 antibody game with 0 million deal with U.S. for omicron-busting hopeful Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals